Related references
Note: Only part of the references are listed.A comparison of low-dose cytarabine and hydroxyurea with or without all-trans retinoic acid for acute myeloid leukemia and high-risk myelodysplastic syndrome in patients not considered fit for intensive treatment
Alan K. Burnett et al.
CANCER (2007)
General approach to, and perspectives on clinical research in, older patients with newly diagnosed acute myeloid leukemia
EH Estey
SEMINARS IN HEMATOLOGY (2006)
Treatment of older patients with acute myeloid leukemia - New agents
AK Burnett et al.
SEMINARS IN HEMATOLOGY (2006)
Bayesian clinical trials
DA Berry
NATURE REVIEWS DRUG DISCOVERY (2006)
Biochemical modulation of cytarabine triphosphate by clofarabine
T Cooper et al.
CANCER CHEMOTHERAPY AND PHARMACOLOGY (2005)
Revised recommendations of the international working group for diagnosis, standardization of response criteria, treatment outcomes, and reporting standards for therapeutic trials in acute myeloid leukemia
BD Cheson et al.
JOURNAL OF CLINICAL ONCOLOGY (2003)
Antitumor activity of 2-fluoro-2 '-deoxyadenosine against tumors that express Escherichia coli purine nucleoside phosphorylase
WB Parker et al.
CANCER GENE THERAPY (2003)
Share Paper
